Haemonetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. 

CEO
Christopher A. Simon
CEOChristopher A. Simon
Employees
3,009
Employees3,009
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1971
Founded1971
Employees
3,009
Employees3,009

HAE Key Statistics

Market cap
4.94B
Market cap4.94B
Price-Earnings ratio
52.87
Price-Earnings ratio52.87
Dividend yield
Dividend yield
Average volume
644.98K
Average volume644.98K
High today
$110.45
High today$110.45
Low today
$107.60
Low today$107.60
Open price
$107.81
Open price$107.81
Volume
1.30M
Volume1.30M
52 Week high
$110.45
52 Week high$110.45
52 Week low
$47.32
52 Week low$47.32

Stock Snapshot

Haemonetics(HAE) stock is priced at $108.40, giving the company a market capitalization of 4.94B. It carries a P/E multiple of 52.87.

On 2026-09-20, Haemonetics(HAE) stock moved within a range of $107.60 to $110.45. With shares now at $108.40, the stock is trading +0.7% above its intraday low and -1.9% below the session's peak.

Trading activity shows a volume of 1.3M, compared to an average daily volume of 644.98K.

Over the past 52 weeks, Haemonetics(HAE) stock has traded between a high of $110.45 and a low of $47.32.

Over the past 52 weeks, Haemonetics(HAE) stock has traded between a high of $110.45 and a low of $47.32.

HAE News

Seeking Alpha 3d
Haemonetics upgraded to Buy at BofA on supply deal with CSL

Bank of America on Thursday upgraded Haemonetics (HAE) to Buy from Neutral, citing a recent supply deal the blood management solutions provider signed with Aust...

Haemonetics upgraded to Buy at BofA on supply deal with CSL
TipRanks 3d
Citi upgrades Haemonetics to Buy on CSL deal upside

Citi upgraded Haemonetics (HAE) to Buy from Neutral with a price target of $123, up from $92. The firm cites potential upside from the company’s non-exclusive s...

TipRanks 5d
Orchestra BioMed receives $6.1M milestone payment from Haemonetics

Orchestra BioMed (OBIO) announced the receipt of $6.1M as the first milestone payment in connection with the previously announced acquisition of Vivasure Medica...

Analyst ratings

75%

of 12 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.